Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Psychiatry/Psychology | Neurology | Family Medicine
Disease Category: Depression
Location: United States, CA

Trial Information

Clinical research study of an investigational medication vs. placebo added to a standard antidepressant treatment in persons with Major Depression.

A multicenter, randomized, double-blind, phase II, safety and efficacy study of xxx vs. placebo in patients with Major Depressive Disorder who exhibit an inadequate response to antidepressant therapy.

Length of study: up to 11 weeks

Number of office visits: up to 8 visits

Qualified participants will receive either investigational study medication or placebo added to standard antidepressant. Participants will receive study related care at no cost and will be compensated for time and travel.

Study inclusion/exclusion criteria
This study is enrolling individuals who:

  • Read and understand English
  • Meet criteria for Major Depressive Disorder
  • Are 18 to 65 years old
  • Have a current inadequate response to an antidepressant
  • Are without serious health problems
  • Do not have certain conditions such as Bipolar, Obsessive-Compulsive Disorder, or Schizophrenia
  • Do not have a recent drug

California Neuroscience Research Medical Group, Inc.
4835 Van Nuys Blvd., Suite 104
Sherman Oaks, CA 91403
Phone: (818) 990-2671
Email: lilit@cnrmg.com

View Map

If you would like to learn more about participating in this study, please send an email message using the form below.

Name:
Address:
City:
State:
Country:
Phone:
Email:  
Message:
 

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.